Skip to main content
. 2023 Jun;29(6):1162–1172. doi: 10.3201/eid2906.230130

Table 5. Vaccine effectiveness against severe COVID-19, 2 or 3 doses versus unvaccinated, Western Australia, Australia, February 1, 2022–May 31, 2022*.

Vaccination status Case-patients, hospital admission or death
Controls
Vaccine effectiveness, % (95% CI)†
Vaccinated Unvaccinated Vaccinated Unvaccinated
Two doses 131 69 148 52 41.9 (4.8–64.5)
Three doses 795 259 982 72 81.7 (73.9–87.2)

*Severe disease was defined as hospitalization for SARS-CoV-2 infection with 7 d of positive SARS-CoV-2 PCR results and/or death from any cause. †Vaccine effectiveness calculated with conditional logistic regression by using case–control pairs matched by week of testing, age group, sex, Aboriginality, Index of Relative Socioeconomic Advantage and Disadvantage, and comorbidity score.